Gerresheimer AG (ETR:GXI – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as €74.50 ($78.42) and last traded at €75.20 ($79.16), with a volume of 151610 shares. The stock had previously closed at €73.85 ($77.74).
Gerresheimer Price Performance
The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36. The stock has a 50-day simple moving average of €83.14 and a 200 day simple moving average of €94.16. The stock has a market capitalization of $2.60 billion, a price-to-earnings ratio of 22.59, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- How to Effectively Use the MarketBeat Ratings Screener
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- 3 Fintech Stocks With Good 2021 Prospects
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.